Hamlin v. BLUE CROSS AND BLUE SHIELD OF LOUISIANA

178 F. Supp. 2d 673, 2001 U.S. Dist. LEXIS 22898, 2001 WL 1677081
CourtDistrict Court, E.D. Louisiana
DecidedDecember 21, 2001
Docket01-225
StatusPublished

This text of 178 F. Supp. 2d 673 (Hamlin v. BLUE CROSS AND BLUE SHIELD OF LOUISIANA) is published on Counsel Stack Legal Research, covering District Court, E.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hamlin v. BLUE CROSS AND BLUE SHIELD OF LOUISIANA, 178 F. Supp. 2d 673, 2001 U.S. Dist. LEXIS 22898, 2001 WL 1677081 (E.D. La. 2001).

Opinion

ORDER AND REASONS

FELDMAN, District Judge.

Before the Court are cross-motions for summary judgment. For the reasons that follow, both motions are DENIED.

Background

William Hamlin and his dependents were covered by his law firm’s Medical Benefit Plan which purchased health insurance from Louisiana Indemnity Company, d/b/a Blue Cross and Blue Shield of Louisiana. The Plan does not pay for health care expenses that are deemed to be not medically necessary. Blue Cross has full *675 discretionary authority in deciding eligibility for benefits, determinations of fact, and construing the terms of the Plan. Blue Cross is both the insurer and the administrator of the Plan.

Hamlin’s daughter Regan suffers from mental illness. 1 In the summer of 1999, Regan was confined for residential treatment at the Meridell Achievement Center in Texas, and Blue Cross paid for her treatment. Regan was thereafter treated as an outpatient by Dr. Betty Muller of the DePaul Tulane Hospital. In February, 2000, Regan relapsed into depression, threw away her medication and ran off to Mississippi, where she was later arrested for car theft. After two weeks in jail, Regan was released to her parents on the condition that she seek treatment in New Orleans.

Regan was admitted to the DePaul Tulane Hospital Psychiatric Unit on March 2 and confined there for almost three weeks. Regan’s situation was first evaluated by a psychiatric social worker, Ann Wilder, who recommended hospitalization based on the information Mr. Hamlin gave her. Wilder reported to the director of DePaul’s adolescent psychiatric unit, Dr. Paul Pelts, who admitted Regan. Dr. David Tucker, a psychiatric resident, then examined Regan and described her admission diagnosis as “Trichotillomania, attention deficit hyperactivity disorder and major depressive episode, recurrent.” Among Dr. Tucker’s findings was that Regan merited a global assessment function score of 40. The next day, Dr. Pelts examined Regan and assigned her a GAF score of 25, which indicates that Dr. Pelts believed Regan to have more severe impairment than Dr. Tucker’s evaluation reflected.

On March 6, DePaul Tulane faxed Re-gan’s chart to Greg Quartano, the Utilization Review Clinical Coordinator for Health Associates of America. Blue Cross contracts with HAA for review of mental health claims. HAA evaluates claims according to a series of internal criteria that it does not share with treating physicians. Hamlin accuses that HAA and Blue Cross have conflicts of interest in evaluating claims because of their economic incentives to deny claims. 2

After reviewing Regan’s records, Quar-tano completed a “Level of Care Justification” form in which he wrote that Regan’s inpatient treatment was not medically necessary because she was not “suicidal, homicidal, a danger to self or others, did not display any thought disorders, or any mood that was incongruent with circumstances.” Quartano recommended that Regan be referred to outpatient family therapy instead of in-patient treatment as had been recommended. In making this assessment, Quartano relied on the Tucker evaluation of Regan and disregarded the findings of Dr. Pelts. Quartano consulted by telephone with another psychiatrist, Dr. Henry Olivier, who also agreed. Hamlin contends that Quartano, contrary to HAA policy of reviewing a patient’s entire medical chart, failed to take into account the diagnosis of Dr. Pelts and Ms. Wilder’s report, and adds that Dr. Olivier did not have Regan’s records before him in reviewing the claim. 3 Quartano then sent *676 Hamlin a denial of benefits letter, stating that the documentation did not indicate that Regan’s DePaul treatment was medically necessary; Hamlin was invited to submit additional documentation that might suggest otherwise.

Hamlin replied to Quartano, and requested that he speak with Dr. Pelts. On March 13 Quartano agreed to set up an “MD to MD review” between doctors Pelts and Olivier to discuss the medical necessity of Regan’s treatment. By the next day, Pelts had concluded that Regan no longer needed hospitalization but did need residential treatment because he believed she was a flight risk and a danger to herself. 4 That same day, March 14, DePaul faxed to Quartano Regan’s medical records and an opinion letter from Dr. Pelts that described his conclusions. Quartano sent the Pelts letter to Olivier, who completed another form rejecting the DePaul admission and also stating that he would not even recommend residential treatment because it had been tried before and failed.

On March 15, Pelts and Olivier discussed by telephone Regan’s treatment. 5 The details of this conversation are, not surprisingly, disputed. It seems clear that Quartano was present with Olivier during the conversation and that Dr. Pelts became frustrated with Dr. Olivier. Hamlin charges that HAA conducted this MD to MD review in bad faith.

After the MD to MD review, Quartano contacted Dr. J. Roniger to conduct still another review of Regan’s treatment needs. It turns out that Dr. Roniger agreed with Dr. Olivier’s conclusions. (There is some dispute as to what documents Roniger had before him in conducting his review). Quartano wrote another letter to Hamlin stating that after the MD to MD review, HAA would stick by its original decision to deny benefits for the DePaul admission.

Quartano completed an “Initial Review Form” dated March 17, evaluating Regan’s suitability for inpatient care. In the form, he stated that Regan’s most recent treatment was her 1999 residential treatment and that there was no medical treatment plan. These statements overlooked Re-gan’s outpatient treatment by Muller and the “immediate treatment plan” described by Tucker in his report. Quartano again relied on the Tucker evaluation. Quartano also sent Hamlin a letter dated March 21 stating that on March 17 HAA determined that the documentation did not confirm the medical necessity of Regan’s residential level of care. 6

*677 Regan remained at DePaul until she was released on March 21. At that point Dr. David Riedel examined Regan at Meridell and admitted her to that facility, concurring that residential treatment was necessary and assigning her a GAF score of 45. Hamlin sent HAA an opinion letter by Muller dated March 22 which supported Regan’s treatment at Meridell. 7 Then on April 4 Olivier wrote stating that Regan needed intensive outpatient therapeutic intervention. 8 Regan was discharged from Meridell on July 29.

After Regan left Meridell, Quartano obtained her medical records from that facility and sent them to Dr. Charles Chester for still another look at medical necessity. Dr. Chester wrote on August 15 stating that Regan did not meet HAA’s criteria for inpatient treatment. On August 22, Quartano wrote Hamlin saying that even Regan’s Meridell treatment was not medically necessary.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
178 F. Supp. 2d 673, 2001 U.S. Dist. LEXIS 22898, 2001 WL 1677081, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hamlin-v-blue-cross-and-blue-shield-of-louisiana-laed-2001.